Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Digestive Diseases and Sciences

Volumn 52, Issue 3, 2007, Pages 727-731

  Kaymakoglu, Sabahattin ^a   Danalioglu, Ahmet ^a   Demir, Kadir ^a   Karaca, Cetin ^a   Akyuz, Filiz ^a   Onel, Derya ^a   Badur, Selim ^a   Cevikbas, Ugur ^a   Besisik, Fatih ^a   Cakaloglu, Yilmaz ^a   Okten, Atilla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; HBeAg negative; Interferon monotherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MOLECULAR HYBRIDIZATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; MALE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33847207514     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9445-1     Document Type: Article

References (28)

1. Maynard JE (1990) Hepatitis B: global importance and need for control. Vaccine 8(suppl):S18-S20
2. Margolis HS, Alter MJ, Hadler SC. Hepatitis B (1991) evolving epidemiology and implications for control. Semin Liver Dis 11:84-92
3. Schalm SW, Thomas HC, Hadziyannis SJ (1990) Chronic hepatitis B. In: Popper H, Schaffner F, eds. Progress in Liver Disease. New York: W.B. Saunders; 443-462
4. Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology 120:1828-1853
5. Santantonio T, Mazzola M, Iacovazzi T, Miglietta A, Guastadisegni A, Pastore G (2000) Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J Hepatol 32:300-306
6. Tassopoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, et al (1999) Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology 29:889-896
7. Carman WF, Jacyna MR, Hadziyannis S, McGarvey M, Karayiannis P, Thomas HC (1989) Mutation preventing formation of 'hepatitis B e antigen' in patients with chronic hepatitis B infection. Lancet ii:588-590
8. Laras A, Koskinas J, Avgidis K, Hadziyannis SJ (1998) Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hep 5:241-248
9. Lindh M, Horal P, Dhillon AP, Furuta Y, Norkrans G (1996) Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 24:494-501
10. Chan HL, Leung NW, Hussain M, Wong ML, Lok AS (2000) Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31:763-768
11. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC (1976) Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295:517-522
12. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661
13. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ (2003) Adefovir dipivoxil for treatment of HbeAg-negative chronic hepatitis B. N Engl J Med 348:800-807
14. Korenman J, Baker B, Waggoner J, et al (1991) Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 114:629-634
15. Gerken G, Gomez J, Lambertico P, et al (1998) Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 74:155-165
16. Hadziyannis SJ (1995) Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1:7-36
17. Brunetto MR, Oliveri F, Demartini A, Calvo P, Manzini P, Cerenzia MT, Bonino F (1991) Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen. J Hepatol 13(suppl 1):S8-11
18. Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, et al (1989) Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 10:198-202
19. Hadziyannis S, Alexopoulou A, Papakonstantinou A, Petraki K, Manesis E (2000) Interferon treatment with or without oral ganciclovir in HBeAgnegative chronic hepatitis B: a randomized study. J Viral Hepat 7:235-240
20. Hadziyannis SJ (1995) Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1:7-36
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435
22. Brunetto MR, Oliveri F, Colombatto P, et al (1995) Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha. J Hepatol 22:42-44
23. Oliveri F, Santantonio T, Bellati G, et al (1999) Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol 94:1366-1372
24. Manesis K, Hadziyannis SJ (2001) Interferon-alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B. Gastroenterology 121:91-100
25. Lampertico P, Del Ninno E, Manzin A, et al (1997) A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology 26:1621-1625
26. Brunetto MR, Oliveri1 F, Coco B (2002) Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 36:263-270
27. Vinayek R, Shakil O (1997) Adverse events associated with interferon-alfa therapy in patients with chronic viral hepatitis. Viral Hep Rev 3:167-177
28. Papatheodoridis GV, Hadziyannis SJ (2001) Diagnosis and management of pre-core mutant chronic hepatitis B. J Viral Hepat 8:311-321